Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain excitatory neurons; strongest in somatotrophs | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.40 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 5 Parkinson's papers of 219 | 0.76 |
| pathways Reactome | 5 pathways; mostly growth signalling | 0.60 |
No case: the score is under the bar. Receipt 6794
Sealed predictions
- SLIT1 in dopamine neurons, braak-0.67 (p 0.047) → +0.27 (p 0.487)receipt 6800
Swarm cases
receipt 6800: SLIT1 in dopamine neurons, braak
- power
- full sample -0.24 (p 0.332, n 18), 95% CI -0.64 to +0.25. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.24 (p 0.332, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.48 (p 0.042, n 18). not the mix.
- skeptic
- leave-one-out range -0.39 to -0.15, sign flips 0; without severely affected donors -0.24 (p 0.332, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLIT1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts